Aurora Cannabis (ACB) Consolidated Net Income (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Consolidated Net Income of -$56.0 million for Q1 2026, down 615.22% year-on-year from $10.9 million in Q1 2025, and down 48722.05% on a QoQ basis from -$114733.8 in Q4 2025.
Aurora Cannabis (ACB) Consolidated Net Income (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Consolidated Net Income for 10 consecutive years, with -$56.0 million the latest figure, recorded in Q1 2026.
- Quarterly Consolidated Net Income fell 615.22% year-over-year to -$56.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$56.4 million (up 99.61% YoY) and the FY2026 annual result came in at -$56.0 million, down 205.6% from the prior year.
- Consolidated Net Income fell to -$56.0 million in Q1 2026 per ACB's latest filing, from -$114733.8 in the prior quarter.
- Over the last five years, Consolidated Net Income for ACB reached as high as $304.0 million in Q2 2024 and fell as low as -$14.6 billion in Q3 2024.
- A 5-year average of -$1.6 billion and a median of -$4.6 million in 2022 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2023 — Consolidated Net Income sank 590811.34% — and 2024, when it jumped 110.76%.
- Year by year, Consolidated Net Income stood at -$13.4 million in 2022, then soared by 94.27% to -$765386.0 in 2023, then soared by 110.76% to $82322.7 in 2024, then tumbled by 239.37% to -$114733.8 in 2025, then tumbled by 48722.05% to -$56.0 million in 2026.
- According to Business Quant data, Consolidated Net Income over the past three periods registered -$56.0 million, -$114733.8, and $84289.7 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | -56.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.02 Mn |
| Dec 31, 2025 | -114,733.81 |
| Sep 30, 2025 | 84,289.66 |
| Jun 30, 2025 | -349,308.85 |
| Mar 31, 2025 | -7.83 Mn |
| Dec 31, 2024 | 82,322.65 |
| Sep 30, 2024 | -14.64 Bn |
| Jun 30, 2024 | 304.00 Mn |
| Mar 31, 2024 | -371,798.72 |
| Dec 31, 2023 | -765,386.02 |
| Sep 30, 2023 | -2.57 Bn |
| Jun 30, 2023 | -8.13 Bn |
| Dec 31, 2022 | -13.35 Mn |
| Sep 30, 2022 | -10.19 Mn |
| Jun 30, 2022 | -1.38 Mn |
| Mar 31, 2022 | -799.25 Mn |
| Dec 31, 2021 | -59.91 Mn |
| Sep 30, 2021 | -9.61 Mn |
| Jun 30, 2021 | 613,399.48 |
| Mar 31, 2021 | -130.19 Mn |